Arcus Biosciences
RCUS • NYSE
Arcus Biosciences is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Terry J. Rosen, with a market cap of $3.1B.
Market Cap$3.1B
Employees577.0
CEOTerry J. Rosen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Arcus Biosciences FAQ
Common questions about Arcus Biosciences
Arcus Biosciences is scheduled to report earnings for Q1 2026 on May 5, 2026 after market close. Analysts estimate revenue of $29.5M.
Arcus Biosciences has approximately 577 employees.